NCT07206433

Brief Summary

Transient Ischaemic Attack (also known as TIA or 'mini-stroke') affects about 46,000 people in the UK each year. It is assumed that people recover fully within 24 hours. However, subtle problems with speaking, and confidence with their communication skills can be long-term. This project will be the first in depth exploration of speaking abilities after recent TIA where there seemed to be a full recovery. The researchers will look for 90 volunteers for detailed testing. Thirty people who have had a TIA for the first time. For comparisons, the researchers will also include 60 volunteers without TIA (30 treated to prevent TIA and stroke; 30 who do not receive prevention treatments). Aims and methods:

  1. 1.To find out if TIA makes speaking difficult.
  2. 2.To find out if people are concerned about their speech and other thinking skills after TIA.
  3. 3.To find out if speaking abilities and people's own views of their communication change over time (about three months after the TIA).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
14mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Oct 2025Jun 2027

First Submitted

Initial submission to the registry

April 23, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

October 3, 2025

Status Verified

April 1, 2025

Enrollment Period

1.7 years

First QC Date

April 23, 2025

Last Update Submit

September 25, 2025

Conditions

Keywords

TIATransient Ischemic Attackspeechlanguage

Outcome Measures

Primary Outcomes (5)

  • Speech rate

    measured as number of words per minute

    From enrollment

  • Mean length of sentence

    measured in number of words

    From enrollment

  • Sentence complexity

    measured as number of complex sentences

    From enrollment

  • Functional Memory Questionnaire

    Patient-reported measure of perceptions of memory, attention, language abilities; score range 0 to 140; higher scores mean a worse outcome

    From enrollment

  • Communication Confidence Rating Scale for Aphasia

    Patient-reported measure of confidence of communication abilities; score range 0 to 600; higher scores mean worse outcome

    From enrollment

Secondary Outcomes (3)

  • Filled pause rate

    From enrollment

  • Lexical richness

    From enrollment

  • Propositional idea density

    From enrollment

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

TIA group: Individuals who have had a recent single medically confirmed TIA following an in-person review at a TIA clinic. Vascular risk factor group: People aged 40-75 with vascular risk factors (e.g., hypertension, diabetes, hyperlipidemia) who receive medical treatment for these conditions and have attended a TIA clinic but were not diagnosed with a TIA. Healthy group: People aged 40-75 who have no self-reported vascular risk factors for which they take medication.

You may not qualify if:

  • Younger than 40 years or older than 85 years of age.
  • English as a secondary language.
  • Neurological conditions affecting cognitive function (e.g., Parkinson's disease, dementia, stroke).
  • Self-reported, pre-existing speech or cognitive problems, developmental or acquired.
  • Demonstrate noticeable difficulties carrying out project-related tasks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Newcastle University

Newcastle upon Tyne, Tyne and Wear, NE1 7RU, United Kingdom

Location

MeSH Terms

Conditions

Ischemic Attack, TransientSpeechLanguage

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesVerbal BehaviorCommunicationBehavior

Study Officials

  • Christos Salis, PhD

    Newcastle University

    PRINCIPAL INVESTIGATOR
  • Lisa Shaw, MD

    Newcastle University

    STUDY CHAIR
  • Christopher Price, MD

    Newcastle University

    STUDY CHAIR
  • Mahmoud Kargar, MSc

    Newcastle University

    STUDY CHAIR

Central Study Contacts

Christos Salis, PhD

CONTACT

Janet Webster, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2025

First Posted

October 3, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

October 3, 2025

Record last verified: 2025-04

Locations